FACTSHEET - Ã PARTIR DU 24 Sep 2021 Solactive Global Healthcare Exposure EUR Index GTR

PERFORMANCE HISTORIQUE*

4,000

3,500

3,000

2,500

2,000

1,500

1,000

500 Jan-2008 Jan-2010 Jan-2012 Jan-2014 Jan-2016 Jan-2018 Jan-2020 Jan-2022 Solactive Global Healthcare Exposure EUR Index GTR

DONNEES CLEFS

ISIN / WKN DE000SL0B9M8 / SL0B9M Valeur / Date initiales 1000 Points / 08.05.2006 Bloomberg / Reuters SOLGHETR Index / .SOLGHETR Prix actuel 3755.76 Calculateur de l’Indice Solactive AG Dividendes Reinvested Type d’Indice Total Return Calcul 09 :00am to 10 :30pm (CET), every 60 seconds Monnaie de l’Indice EUR Données Available daily back to 08.05.2006 Composants de l’Indice 30 FACTSHEET - Ã PARTIR DU 24 Sep 2021 Solactive Global Healthcare Exposure EUR Index GTR

STATISTIQUES

30J 90J 180J 360J YTD Depuis sa Création Performance -2.30% 0.80% 3.23% 15.07% 10.38% 275.58% Performance (p.a.) - - - - - 8.98% Volatilité (p.a.) 5.97% 7.14% 7.99% 9.50% 9.30% 12.37% Maxi 3856.14 3909.47 3909.47 3909.47 3909.47 3909.47 Mini 3745.37 3730.42 3486.09 3158.24 3312.67 633.57 Sharpe Ratio -4.04 0.54 0.90 1.66 1.61 0.77 Max. Drawdown -2.87% -4.20% -4.94% -5.94% -5.94% -42.79% VaR 95 \ 99 -15.1% \ -19.1% -18.8% \ -35.5% CVaR 95 \ 99 -19.4% \ -30.8% -30.2% \ -51.6%

EXPOSITION AU RISQUE DE CHANGE EXPOSITION AU RISQUE-PAYS

USD 37.8% US 37.8% JPY 30.4% JP 30.4% EUR 14.8% CH 7.5% CHF 7.5% GB 6.2% Others 9.5% Others 18.1%

COMPOSANTS 24 Sep 2021

Code Monnaie Pays Société Poids

PG UN Equity USD US PROCTER & GAMBLE CO 5.04% 2269 JT Equity JPY JP MEIJI HOLDINGS CO LTD 4.39% JNJ UN Equity USD US JOHNSON & JOHNSON 4.39% NOVN SE Equity CHF CH NOVARTIS AG 4.04% 8630 JT Equity JPY JP SOMPO HOLDINGS INC 3.73% MRK UN Equity USD US MERCK & CO. INC. 3.71% GILD UW Equity USD US GILEAD SCIENCES INC 3.60% PFE UN Equity USD US PFIZER INC 3.58% ROG SE Equity CHF CH ROCHE HOLDING AG 3.51% 4578 JT Equity JPY JP OTSUKA HOLDINGS CO LTD ORD 3.50% 4502 JT Equity JPY JP TAKEDA PHARMACEUTICAL 3.40% SAN FP Equity EUR FR SANOFI SA 3.38% 9735 JT Equity JPY JP CO LTD ORD 3.32% BNZL LN Equity GBP GB BUNZL PLC 3.30% ESSITYB SS Equity SEK SE ESSITY AB CLASS B 3.28% FACTSHEET - Ã PARTIR DU 24 Sep 2021 Solactive Global Healthcare Exposure EUR Index GTR

Code Monnaie Pays Société Poids

REC IM Equity EUR IT RECORDATI SPA 3.25% 7459 JT Equity JPY JP MEDIPAL HLDGS (MEDICEO PALTAC) ORD 3.15% MMM UN Equity USD US 3M COMPANY 3.10% BMY UN Equity USD US BRISTOL-MYERS SQUIBB CO 3.06% 3401 JT Equity JPY JP LTD 3.06% CVS UN Equity USD US CVS HEALTH CORP 3.01% 4503 JT Equity JPY JP INC 3.00% ABBV UN Equity USD US ABBVIE INC 2.96% PHIA NA Equity EUR NL KONINKLIJKE PHILIPS NV 2.94% RKT LN Equity GBP GB RECKITT BENCKISER GROUP PLC 2.88% 6988 JT Equity JPY JP CORP 2.85% AMGN UW Equity USD US AMGEN INC 2.75% FME GY Equity EUR DE FRESENIUS MEDICAL CARE AG & CO KGAA 2.66% FRE GY Equity EUR DE FRESENIUS SE & CO KGAA 2.59% CLX UN Equity USD US CLOROX COMPANY 2.58% FACTSHEET - Ã PARTIR DU 24 Sep 2021 Solactive Global Healthcare Exposure EUR Index GTR

For more information, please visit www.solactive.com.

© Solactive AG, 2021. All rights reserved. The information contained in this factsheet is impersonal, not tailored to the needs of any person, entity or group of persons and for informational purposes only. The information contained herein has been obtained from public sources believed to be reliable, but no representation or warranty, express or implied, is made that such information is accurate or complete and it should not be relied upon as such. The content is provided on an ”as is” basis. Solactive AG accepts no responsibility or liability for any errors or for any loss from use of this factsheet or any of the information or data contained herein. In no event shall Solactive AG be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the factsheets and its content even if advised of the possibility ofsuchdamages. It is not possible to invest directly in an index. Exposure to assets represented by an index is available through investable financial instruments that seek to provide an investment return based on the performance of an index. A decision to invest in any such financial instrument should not be made in reliance on any of the statements set forth in this document. Prospective investors are advised to make an investment in any such financial instrument only after carefully considering the risks associated with investing in such financial instruments, as detailed in an offering memorandum or similar document that is prepared by or on behalf of the issuer of the financial instrument or vehicle. The financial instruments are not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express orimplicitguarantee or assurance either with regard to the results of using the Index and/or Index trade mark or the Index level at any time or in any other respect. Solactive AG makes no assurance that financial instruments based on the index will accurately track index performance or provide positive investment returns. Solactive AG isnotaninvestment adviser and nothing in this factsheet constitutes a recommendation by Solactive AG to invest capital in financial instruments nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in a financial instrument. Inclusion of a security within an index is not a recommendation by Solactive AGtobuy, sell, or hold such security, nor is it considered to be investment advice. Past performance should not be considered as indication or guarantee of any future results. Charts and graphs are provided for illustrative purposes. This info service is offered exclusively by Solactive AG, Platz der Einheit 1, D-60327 Frankfurt am Main|E-Mail : [email protected] ”Solactive”, ”Solactive GBS”, ”German Index Engineering” and the logo are registered trademarks of Solactive AG. The information in this document does not constitute tax, legal or investment advice. The factsheet is proprietary to Solactive AG. Its content may not be modified, reproduced, redistributed or stored in a retrieval system in whole or in part without the prior written consent of Solactive AG.